Status:

NOT_YET_RECRUITING

Shenfu Injection Modulates Carotid Elasticity in Septic Shock

Lead Sponsor:

First Affiliated Hospital of Wannan Medical College

Collaborating Sponsors:

Wuhu City Second People's Hospital

Conditions:

Septic Shock

Vascular Dysfunction

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

What is this study about? We are studying whether Shenfu Injection (a traditional Chinese herbal medicine) can help improve blood vessel health in patients with septic shock-a severe complication of i...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Age ≥ 18 years.
  • Diagnosis of sepsis or septic shock in the acute phase, as defined by the -Sepsis-3 criteria (confirmed infection with Sequential Organ Failure Assessment \[SOFA\] score ≥ 2 points above baseline).
  • Voluntary participation with written informed consent provided by the patient or legally authorized representative.
  • Exclusion Criteria
  • Severe carotid atherosclerosis (e.g., carotid Intima-Media Thickness (IMT)\>1.2 mm or confirmed plaque formation) diagnosed by prior imaging.
  • Significant cardiovascular comorbidities that may confound hemodynamic assessments, including:
  • Severe cardiomyopathy (e.g., ejection fraction \<30%).
  • Uncontrolled arrhythmias (e.g., ventricular tachycardia, atrial fibrillation with rapid ventricular response).
  • Congenital heart disease with hemodynamic instability.
  • Active hepatic or renal insufficiency (e.g., Child-Pugh class C, dialysis dependence) or advanced systemic diseases (e.g., metastatic malignancy, terminal illness).
  • Poor ultrasound image quality precluding reliable speckle tracking analysis (e.g., inadequate acoustic window, motion artifacts).
  • Pregnancy or lactation (due to potential hormonal influences on vascular physiology).
  • Withdrawal from the study or inability to complete follow-up assessments (e.g., non-compliance, transfer to another facility).

Exclusion

    Key Trial Info

    Start Date :

    April 15 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 30 2026

    Estimated Enrollment :

    48 Patients enrolled

    Trial Details

    Trial ID

    NCT06915506

    Start Date

    April 15 2025

    End Date

    April 30 2026

    Last Update

    April 8 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

    Wuhu, Anhui, China, 241000